A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries
NCT: NCT03037411 · COMPLETED
Реклама
NCT IDNCT03037411
СтатусCOMPLETED
Дата начала2016-12-13
Завершение2022-03-24
Краткое описание
The REGAL study is a European, prospective, multi-center Post-Market Clinical Follow-up (PMCF) trial providing additional data including health economics data to support the use of the ELUVIA stent in the treatment of lesions located in the femoropopliteal arteries.
Официальный источник
Открыть на ClinicalTrials.gov →Данные получены через API ClinicalTrials.gov. Актуальный статус смотрите в официальной записи.